Cannabinoid Mapping

Cannabinoid Mapping refers to the systematic identification and quantification of cannabinoid profiles across cannabis genetics. Rather than focusing solely on THC or CBD content, breeders and researchers in this category analyze the full spectrum of minor cannabinoids—including CBG, CBC, CBN, and CBDA—to understand how different strains express these compounds. This approach emerged as analytical technology (gas chromatography, HPLC) became more accessible, allowing cultivators to track cannabinoid inheritance patterns and predict offspring expression. Lineage records increasingly report cannabinoid ratios alongside cannabinoid percentages, treating these profiles as heritable traits comparable to terpene expression. Understanding cannabinoid mapping is essential for breeders seeking to stabilize novel ratios or develop cultivars with distinct minor-cannabinoid signatures.

Breeders use cannabinoid mapping to select parent plants with complementary cannabinoid genetics, identify recessive traits worth isolating, and develop F1 hybrids with predictable minor-cannabinoid output. Detailed cannabinoid analysis enables targeted crosses aimed at specific ratios—such as high-CBG or balanced CBD:CBG phenotypes—that may appeal to processors and cultivators working outside tra